This article discusses the SNAP2 trial, a randomized controlled study designed to evaluate whether a tailored intervention can enhance adherence to nicotine replacement therapy among pregnant women.
The goal is to determine if this approach is effective and cost-efficient in promoting smoking cessation during pregnancy, ultimately improving maternal and fetal health outcomes.